Literature DB >> 17447132

Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs.

Don C Des Jarlais1, Naomi Braine, Patricia Friedmann.   

Abstract

OBJECTIVE: To assess variation in injection risk behavior among unstably housed/homeless injecting drug users (IDUs) across programs in a national sample of US syringe exchange programs.
METHODS: About 23 syringe exchange programs were selected through stratified random sampling of moderate to very large US syringe exchange programs operating in 2001-2005. Subjects at each program were randomly sampled. Risk behavior interviews were collected using audio-computer assisted self-interviewing (A-CASI). "Unstable housing/homelessness" was operationally defined as having lived "on the street or in a shanty" or "living in a shelter or single room occupancy hotel (SRO)" at any time in the 6 months prior to the interview. "Receptive sharing" was operationally defined as having injected with a needle or syringe that "had been used by someone else" in the 30 days prior to the interview. Six very large and nine moderate-to-large programs had at least 50 subjects who reported unstable housing, and these 15 programs were used in the analyses.
RESULTS: There was considerable variation among the 15 programs in the percentages of unstably housed participants (range from 35 to 74%, P < 0.0001), and in the percentages of unstably housed participants who reported receptive sharing (range from 8 to 52%, P < 0.0001). At each of the 15 programs, unstably housed exchange participants were approximately twice as likely to report receptive sharing than were stably housed participants. The weighted mean odds ratio was 2.02, 95% confidence interval, 1.68-2.41 (random effects model) and there was no statistically significant variation in these odds ratios. Across the 15 programs, receptive sharing among unstably housed participants was highly correlated with receptive sharing among stably housed participants (r = 0.95, P < 0.001, 90% of variance among unstably housed "explained" by variance among stably housed).
CONCLUSIONS: The programs clearly differ in the extent to which they are attracting unstably housed IDUs as participants. The consistency of more frequent injection risk behavior among unstably housed exchange participants and the lack of significant variation in the odds ratios for increased injection risk suggests that none of the programs were "better" or "worse" at reducing injection risk behavior among unstably housed participants. Reduction in injecting risk behavior among syringe exchange participants may require greater efforts to provide stable housing or the development of dramatically new interventions to reduce injecting risk behavior among IDUs with persistent unstable housing.

Entities:  

Mesh:

Year:  2007        PMID: 17447132     DOI: 10.1007/s10461-007-9227-6

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  30 in total

1.  Linking HIV-positive jail inmates to treatment, care, and social services after release: results from a qualitative assessment of the COMPASS Program.

Authors:  Amy Nunn; Alexandra Cornwall; Jeannia Fu; Lauri Bazerman; Helen Loewenthal; Curt Beckwith
Journal:  J Urban Health       Date:  2010-12       Impact factor: 3.671

2.  Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study.

Authors:  Hannah Cooper; Don Des Jarlais; Zev Ross; Barbara Tempalski; Brian H Bossak; Samuel R Friedman
Journal:  J Urban Health       Date:  2012-08       Impact factor: 3.671

3.  Big Events in Greece and HIV Infection Among People Who Inject Drugs.

Authors:  Georgios K Nikolopoulos; Vana Sypsa; Stefanos Bonovas; Dimitrios Paraskevis; Melpomeni Malliori-Minerva; Angelos Hatzakis; Samuel R Friedman
Journal:  Subst Use Misuse       Date:  2015-02-27       Impact factor: 2.164

4.  Expansion of Syringe Service Programs in the United States, 2015-2018.

Authors:  Don C Des Jarlais; Jonathan Feelemyer; Paul LaKosky; Kathryn Szymanowski; Kamyar Arasteh
Journal:  Am J Public Health       Date:  2020-02-20       Impact factor: 9.308

5.  I heard about it from a friend: assessing interest in buprenorphine treatment.

Authors:  Aaron D Fox; Pooja A Shah; Nancy L Sohler; Carolina M Lopez; Joanna L Starrels; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

6.  Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece.

Authors:  Vana Sypsa; Dimitrios Paraskevis; Meni Malliori; Georgios K Nikolopoulos; Anastasios Panopoulos; Maria Kantzanou; Antigoni Katsoulidou; Mina Psichogiou; Anastasios Fotiou; Anastasia Pharris; Marita Van De Laar; Lucas Wiessing; Don Des Jarlais; Samuel R Friedman; Angelos Hatzakis
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

7.  Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.

Authors:  Robin A Pollini; Remedios Lozada; Manuel Gallardo; Perth Rosen; Alicia Vera; Armando Macias; Lawrence A Palinkas; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2010-06

8.  Unprotected sex among heterosexually active homeless men: results from a multi-level dyadic analysis.

Authors:  David P Kennedy; Suzanne L Wenzel; Ryan Brown; Joan S Tucker; Daniela Golinelli
Journal:  AIDS Behav       Date:  2013-06

9.  Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities.

Authors:  Robin A Pollini; Kimberly C Brouwer; Remedios M Lozada; Rebeca Ramos; Michelle F Cruz; Carlos Magis-Rodriguez; Patricia Case; Scott Burris; Minya Pu; Simon D W Frost; Lawrence A Palinkas; Cari Miller; Steffanie A Strathdee
Journal:  Addiction       Date:  2007-11-20       Impact factor: 6.526

10.  A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.

Authors:  Marie Jauffret-Roustide; Yann Le Strat; Elisabeth Couturier; Damien Thierry; Marc Rondy; Martine Quaglia; Nicolas Razafandratsima; Julien Emmanuelli; Gaelle Guibert; Francis Barin; Jean-Claude Desenclos
Journal:  BMC Infect Dis       Date:  2009-07-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.